官网网址:www.chemegen.com EGFR Inhibitor 2 is a selective and potent EGFR inhibitor, with IC50s of 7.92 nM and 0.218 nM for EGFR (WT) and EGFR (mutant C797S/T790M/L858R) respectively, extracted from patent WO2019015655A1. EGFR Inhibitor 2 shows anti-tumor activity. ChemeGen 作为优秀的抑制剂、激动剂及新型生命科学试剂的供应商,致力于为广大科研、商业实验室的科学研究者提供高品质的产品与技术服务,不断促进生命科学领域的新技术发展。